Individuals with Lynch syndrome carry a heterozygous hereditary pathogenic or likely pathogenic variant (PV or LPV) in one of the tumor suppressor genes involved in mismatch repair (MMR genes), MLH1, MSH2, MSH6, PMS2, or EPCAM, which leads to the loss of one functional copy of these genes [2]. This evidence concerns the gene PMS2 and Lynch syndrome.